Home > Insider Trading > Filing (0001209191-12-000685)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949699	Pharmacyclics Inc	PCYC	Pharmaceutical Preparations (2834)	943148201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1507649	Gregory Hemmi	C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085	Vp Chemical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-12-30	6,563	$7.39	26,539	No	4	M	Direct
Common Stock	Disposition	2011-12-30	6,563	$14.90	19,976	No	4	S	Direct
Common Stock	Acquisiton	2011-12-30	8,437	$7.39	28,413	No	4	M	Direct
Common Stock	Disposition	2011-12-30	8,437	$14.93	19,976	No	4	S	Direct
Common Stock	Acquisiton	2011-12-30	3,125	$4.25	23,101	No	4	M	Direct
Common Stock	Disposition	2011-12-30	3,125	$14.90	19,976	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-30	6,563	$0.00	6,563	$7.39
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-30	8,437	$0.00	8,437	$7.39
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-30	3,125	$0.00	3,125	$4.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,437	2002-02-05	2012-02-05	No	4	M	Direct
0	2002-02-05	2012-05-05	No	4	M	Direct
1,875	2002-06-12	2012-06-12	No	4	M	Direct

Footnotes

Sale of shares pursuant to Rule 10b5-1 Plan adopted on December 16, 2011.
Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $14.82 to $15.05. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $14.84 to $15.05. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Option granted under the issuer's 1995 Stock Option Plan in a transaction exempt under rule 16b-3(d). Option shares vesting in a series of forty-eight (48) equal and successive monthly installments.